Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipsu oral gel for radiotherapy-induced oral mucositis in head and neck cancer
ChiCTR2100055088Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Jan 2022
- Modality
- Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Ipsu oral gel in head and neck cancer (HNC) and stomatitis (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: oral mucositis, pain and 2 more. Started Jan 2022; status: recruiting.
02
Drugs
Ipsu oral gel
03
Conditions
head and neck cancer (HNC)stomatitis
Beyond the preview
Go deeper on ChiCTR2100055088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100055088.